 Hao Dun
Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 4 | 2026 | 680 | 0.700 |
Why?
| | Tacrolimus | 3 | 2017 | 196 | 0.660 |
Why?
| | Transplantation, Heterotopic | 1 | 2020 | 16 | 0.640 |
Why?
| | Monocytes | 4 | 2025 | 539 | 0.620 |
Why?
| | Aorta, Abdominal | 1 | 2020 | 52 | 0.620 |
Why?
| | Graft Rejection | 5 | 2022 | 521 | 0.590 |
Why?
| | Kidney Transplantation | 6 | 2017 | 712 | 0.570 |
Why?
| | Immunosuppressive Agents | 4 | 2017 | 838 | 0.520 |
Why?
| | T-Lymphocytes, Regulatory | 3 | 2017 | 409 | 0.520 |
Why?
| | B-Lymphocytes | 2 | 2020 | 870 | 0.440 |
Why?
| | Macrophages | 4 | 2026 | 1507 | 0.410 |
Why?
| | Receptors, Immunologic | 5 | 2025 | 208 | 0.380 |
Why?
| | Receptors, CCR2 | 2 | 2025 | 39 | 0.380 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2017 | 919 | 0.320 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2017 | 1140 | 0.310 |
Why?
| | Macaca fascicularis | 8 | 2017 | 70 | 0.290 |
Why?
| | Graft Survival | 5 | 2026 | 518 | 0.270 |
Why?
| | Stromal Cells | 1 | 2026 | 121 | 0.230 |
Why?
| | Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2025 | 7 | 0.220 |
Why?
| | Neutrophil Infiltration | 1 | 2025 | 104 | 0.210 |
Why?
| | Arginase | 1 | 2024 | 26 | 0.210 |
Why?
| | Coronary Vessels | 1 | 2026 | 246 | 0.210 |
Why?
| | Cell Communication | 1 | 2026 | 328 | 0.210 |
Why?
| | Animals | 22 | 2026 | 38030 | 0.190 |
Why?
| | Single-Cell Analysis | 1 | 2026 | 362 | 0.190 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 296 | 0.180 |
Why?
| | Mesenchymal Stem Cell Transplantation | 2 | 2013 | 59 | 0.180 |
Why?
| | Mice, Inbred C57BL | 11 | 2026 | 5983 | 0.180 |
Why?
| | Myocardium | 3 | 2025 | 934 | 0.180 |
Why?
| | Membrane Glycoproteins | 1 | 2025 | 499 | 0.180 |
Why?
| | Mice | 13 | 2026 | 18329 | 0.180 |
Why?
| | Disease Models, Animal | 6 | 2026 | 4560 | 0.170 |
Why?
| | Mice, Inbred BALB C | 2 | 2022 | 1261 | 0.170 |
Why?
| | Phenprocoumon | 1 | 2020 | 4 | 0.160 |
Why?
| | Heart Injuries | 1 | 2020 | 42 | 0.150 |
Why?
| | Coronary Artery Disease | 1 | 2026 | 749 | 0.150 |
Why?
| | Transcriptome | 1 | 2026 | 1038 | 0.150 |
Why?
| | Drug Therapy, Combination | 3 | 2017 | 1044 | 0.150 |
Why?
| | Neutrophils | 1 | 2025 | 1124 | 0.150 |
Why?
| | Fatty Acids | 1 | 2022 | 457 | 0.140 |
Why?
| | Acute Lung Injury | 1 | 2022 | 305 | 0.140 |
Why?
| | Positron-Emission Tomography | 1 | 2020 | 343 | 0.140 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 326 | 0.140 |
Why?
| | Receptors, Lysosphingolipid | 1 | 2017 | 13 | 0.130 |
Why?
| | Myocardial Infarction | 1 | 2024 | 1210 | 0.120 |
Why?
| | Antibodies, Monoclonal | 2 | 2014 | 1505 | 0.120 |
Why?
| | Abatacept | 1 | 2016 | 56 | 0.120 |
Why?
| | Fingolimod Hydrochloride | 1 | 2017 | 40 | 0.120 |
Why?
| | Allografts | 3 | 2026 | 152 | 0.120 |
Why?
| | Cell Differentiation | 1 | 2024 | 2046 | 0.120 |
Why?
| | CD40 Antigens | 2 | 2014 | 90 | 0.120 |
Why?
| | Immunoconjugates | 1 | 2016 | 138 | 0.110 |
Why?
| | Immunologic Memory | 1 | 2017 | 368 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 875 | 0.100 |
Why?
| | Mycophenolic Acid | 1 | 2014 | 120 | 0.100 |
Why?
| | Reperfusion Injury | 2 | 2009 | 293 | 0.100 |
Why?
| | Chondrogenesis | 1 | 2013 | 88 | 0.090 |
Why?
| | Knee Injuries | 1 | 2013 | 122 | 0.090 |
Why?
| | Male | 15 | 2026 | 72843 | 0.080 |
Why?
| | Cartilage | 1 | 2013 | 197 | 0.080 |
Why?
| | Regeneration | 1 | 2013 | 197 | 0.080 |
Why?
| | Antilymphocyte Serum | 1 | 2010 | 57 | 0.080 |
Why?
| | Kidney Failure, Chronic | 1 | 2016 | 599 | 0.080 |
Why?
| | Osteoarthritis | 1 | 2013 | 200 | 0.080 |
Why?
| | Urinary Incontinence | 1 | 2010 | 65 | 0.080 |
Why?
| | Mice, Knockout | 3 | 2025 | 3124 | 0.080 |
Why?
| | Signal Transduction | 5 | 2026 | 5216 | 0.080 |
Why?
| | Ureteral Obstruction | 1 | 2010 | 63 | 0.070 |
Why?
| | Early Growth Response Protein 1 | 1 | 2009 | 32 | 0.070 |
Why?
| | Knee Joint | 1 | 2013 | 428 | 0.070 |
Why?
| | Sirolimus | 1 | 2010 | 280 | 0.070 |
Why?
| | Cartilage, Articular | 1 | 2013 | 349 | 0.070 |
Why?
| | Liver | 2 | 2009 | 1896 | 0.070 |
Why?
| | Skin | 1 | 2013 | 753 | 0.070 |
Why?
| | Interleukin-10 | 1 | 2009 | 309 | 0.060 |
Why?
| | T-Lymphocyte Subsets | 1 | 2009 | 418 | 0.060 |
Why?
| | Neointima | 1 | 2026 | 18 | 0.060 |
Why?
| | Receptor for Advanced Glycation End Products | 4 | 2009 | 33 | 0.060 |
Why?
| | Cell Lineage | 2 | 2024 | 377 | 0.060 |
Why?
| | Inflammation Mediators | 2 | 2006 | 506 | 0.060 |
Why?
| | Interferon Type I | 1 | 2026 | 147 | 0.060 |
Why?
| | Nitriles | 1 | 2026 | 207 | 0.050 |
Why?
| | Liver Regeneration | 1 | 2005 | 46 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2026 | 270 | 0.050 |
Why?
| | NF-kappa B | 2 | 2005 | 666 | 0.050 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2009 | 1217 | 0.050 |
Why?
| | Hepatitis | 1 | 2004 | 43 | 0.050 |
Why?
| | Cell Hypoxia | 1 | 2024 | 247 | 0.050 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2024 | 139 | 0.050 |
Why?
| | Ligands | 2 | 2022 | 665 | 0.050 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2026 | 449 | 0.050 |
Why?
| | Flow Cytometry | 2 | 2020 | 1162 | 0.050 |
Why?
| | Multiple Sclerosis | 1 | 2009 | 489 | 0.050 |
Why?
| | Treatment Outcome | 2 | 2017 | 11772 | 0.050 |
Why?
| | Reactive Oxygen Species | 1 | 2006 | 611 | 0.050 |
Why?
| | Liver Diseases | 1 | 2006 | 305 | 0.050 |
Why?
| | Pyrimidines | 1 | 2026 | 530 | 0.050 |
Why?
| | Ventricular Remodeling | 1 | 2024 | 278 | 0.050 |
Why?
| | Osteopontin | 1 | 2022 | 35 | 0.040 |
Why?
| | Pyrazoles | 1 | 2026 | 517 | 0.040 |
Why?
| | Survival Rate | 4 | 2010 | 2090 | 0.040 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2022 | 119 | 0.040 |
Why?
| | Humans | 9 | 2026 | 145475 | 0.040 |
Why?
| | Kidney | 2 | 2022 | 1497 | 0.040 |
Why?
| | Isotope Labeling | 1 | 2020 | 82 | 0.040 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2010 | 82 | 0.040 |
Why?
| | CD4 Antigens | 2 | 2010 | 137 | 0.040 |
Why?
| | Tissue Donors | 1 | 2022 | 420 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 319 | 0.040 |
Why?
| | Bone Marrow Cells | 1 | 2020 | 321 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2022 | 1067 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2014 | 992 | 0.030 |
Why?
| | B7-2 Antigen | 1 | 2016 | 27 | 0.030 |
Why?
| | Kidney Function Tests | 1 | 2016 | 156 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3155 | 0.030 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2016 | 177 | 0.030 |
Why?
| | Female | 2 | 2022 | 78845 | 0.030 |
Why?
| | Transplantation, Homologous | 1 | 2016 | 418 | 0.030 |
Why?
| | CD40 Ligand | 1 | 2014 | 40 | 0.030 |
Why?
| | Antigens, CD20 | 1 | 2014 | 34 | 0.030 |
Why?
| | Biotinylation | 1 | 2014 | 37 | 0.030 |
Why?
| | Colony-Forming Units Assay | 1 | 2013 | 95 | 0.020 |
Why?
| | Collagenases | 1 | 2013 | 22 | 0.020 |
Why?
| | Cell Separation | 1 | 2014 | 305 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2016 | 765 | 0.020 |
Why?
| | Cytokines | 2 | 2014 | 2067 | 0.020 |
Why?
| | Clone Cells | 1 | 2013 | 263 | 0.020 |
Why?
| | Matrix Metalloproteinases | 1 | 2013 | 95 | 0.020 |
Why?
| | Creatinine | 1 | 2014 | 515 | 0.020 |
Why?
| | Joints | 1 | 2013 | 106 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 848 | 0.020 |
Why?
| | Isoantigens | 1 | 2010 | 17 | 0.020 |
Why?
| | Haplorhini | 1 | 2010 | 52 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2010 | 200 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 355 | 0.020 |
Why?
| | Drug Synergism | 1 | 2010 | 354 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1716 | 0.020 |
Why?
| | Random Allocation | 1 | 2010 | 365 | 0.020 |
Why?
| | P-Selectin | 1 | 2009 | 29 | 0.020 |
Why?
| | Chemokine CXCL2 | 1 | 2009 | 41 | 0.020 |
Why?
| | Self Tolerance | 1 | 2009 | 26 | 0.020 |
Why?
| | Clinical Protocols | 1 | 2010 | 280 | 0.020 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 153 | 0.020 |
Why?
| | Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 126 | 0.020 |
Why?
| | Apoptosis | 2 | 2009 | 2440 | 0.020 |
Why?
| | Postoperative Care | 1 | 2010 | 286 | 0.020 |
Why?
| | Gene Expression Regulation | 2 | 2009 | 2597 | 0.020 |
Why?
| | Acute Disease | 1 | 2010 | 1036 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2010 | 1266 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 451 | 0.020 |
Why?
| | Gene Deletion | 1 | 2009 | 391 | 0.020 |
Why?
| | Reoperation | 1 | 2010 | 633 | 0.020 |
Why?
| | Dendritic Cells | 1 | 2009 | 499 | 0.010 |
Why?
| | Glycation End Products, Advanced | 1 | 2006 | 81 | 0.010 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2006 | 138 | 0.010 |
Why?
| | Transcription Factor AP-1 | 1 | 2004 | 79 | 0.010 |
Why?
| | Acetaminophen | 1 | 2006 | 267 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 4148 | 0.010 |
Why?
| | Time Factors | 1 | 2014 | 7123 | 0.010 |
Why?
| | Hepatectomy | 1 | 2005 | 274 | 0.010 |
Why?
| | Cell Death | 1 | 2004 | 382 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2004 | 693 | 0.010 |
Why?
| | Homeostasis | 1 | 2004 | 642 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2005 | 2188 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2005 | 2507 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2010 | 2970 | 0.010 |
Why?
| | Risk Factors | 1 | 2010 | 10885 | 0.010 |
Why?
|
|
Dun's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|